Literature DB >> 23579431

High microvessel density in pancreatic ductal adenocarcinoma is associated with high grade.

Anca Barău1, Amparo Ruiz-Sauri, Gerardo Valencia, Maria Del Carmen Gómez-Mateo, Luis Sabater, Antonio Ferrandez, Antonio Llombart-Bosch.   

Abstract

The objectives of this work are to study angiogenesis in pancreatic ductal adenocarcinoma using computerized morphometric and image analysis and to compare the microvascular density in intratumoral and peritumoral areas and normal pancreatic tissue. Microvascular density was analyzed in 60 cases of pancreatic ductal adenocarcinoma and 30 samples of normal pancreatic tissue using an avidin-biotin immunoperoxidase technique with an anti-CD31 antibody. Microvascular density (MVD) was analyzed through digital microimaging and computerized analysis. The blood vessel density in the tumor was significantly higher than in peritumoral areas and in normal pancreatic tissue. Well differentiated pancreatic ductal adenocarcinomas contained higher MVD than poorly differentiated carcinomas. In pancreatic adenocarcinoma, MVD is higher than in peritumoral tissue or normal pancreatic tissue.

Entities:  

Mesh:

Year:  2013        PMID: 23579431     DOI: 10.1007/s00428-013-1409-1

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  31 in total

1.  Angiogenesis: a prognostic determinant in pancreatic cancer?

Authors:  Jill A van der Zee; Casper H J van Eijck; Wim C J Hop; Herman van Dekken; Bilyana M Dicheva; Ann L B Seynhaeve; Gerben A Koning; Alexander M M Eggermont; Timo L M ten Hagen
Journal:  Eur J Cancer       Date:  2011-09-28       Impact factor: 9.162

Review 2.  Tumor-stroma interactions in pancreatic ductal adenocarcinoma.

Authors:  Daruka Mahadevan; Daniel D Von Hoff
Journal:  Mol Cancer Ther       Date:  2007-04-03       Impact factor: 6.261

3.  Analysis of microvessels in pancreatic cancer: by light microscopy, confocal laser scan microscopy, and electron microscopy.

Authors:  Kenji Takagi; Tadahiro Takada; Hodaka Amano; Masahiro Yoshida; Humihiko Miura; Naoyuki Toyota; Keita Wada; Ichirou Takahashi
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-08-01

4.  Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.

Authors:  H Han; J F Silverman; T S Santucci; R S Macherey; T A d'Amato; M Y Tung; R J Weyant; R J Landreneau
Journal:  Ann Surg Oncol       Date:  2001 Jan-Feb       Impact factor: 5.344

5.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

6.  Tumor angiogenesis as a prognostic predictor in pancreatic cancer.

Authors:  S Karademir; S Sökmen; C Terzi; O Sağol; E Ozer; H Astarcioğlu; A Coker; I Astarcioğlu
Journal:  J Hepatobiliary Pancreat Surg       Date:  2000

7.  A high peripheral microvessel density count correlates with a poor prognosis in pancreatic cancer.

Authors:  Kenji Takagi; Tadahiro Takada; Hodaka Amano
Journal:  J Gastroenterol       Date:  2005-04       Impact factor: 7.527

8.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.

Authors:  D M Brizel; S P Scully; J M Harrelson; L J Layfield; J M Bean; L R Prosnitz; M W Dewhirst
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

Review 9.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

Review 10.  Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors.

Authors:  N Weidner
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

View more
  11 in total

1.  A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer.

Authors:  Sepideh Gholami; Andrew Marano; Nanhai G Chen; Richard J Aguilar; Alexa Frentzen; Chun-Hao Chen; Emil Lou; Sho Fujisawa; Clarisse Eveno; Laurence Belin; Pat Zanzonico; Aladar Szalay; Yuman Fong
Journal:  Breast Cancer Res Treat       Date:  2014-11-13       Impact factor: 4.872

2.  Development of a multicellular pancreatic tumor microenvironment system using patient-derived tumor cells.

Authors:  Daniel Gioeli; Chelsi J Snow; Michael B Simmers; Stephen A Hoang; Robert A Figler; J Ashe Allende; Devin G Roller; J Thomas Parsons; Julia D Wulfkuhle; Emanuel F Petricoin; Todd W Bauer; Brian R Wamhoff
Journal:  Lab Chip       Date:  2019-03-27       Impact factor: 6.799

Review 3.  Prognostication and response assessment in liver and pancreatic tumors: The new imaging.

Authors:  Riccardo De Robertis; Paolo Tinazzi Martini; Emanuele Demozzi; Gino Puntel; Silvia Ortolani; Sara Cingarlini; Andrea Ruzzenente; Alfredo Guglielmi; Giampaolo Tortora; Claudio Bassi; Paolo Pederzoli; Mirko D'Onofrio
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

4.  Overexpressions of DLL4 and CD105 are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma.

Authors:  Liangjing Zhou; Leilai Yu; Guoping Ding; Wenchao Chen; Sixin Zheng; Liping Cao
Journal:  Pathol Oncol Res       Date:  2015-05-19       Impact factor: 3.201

5.  Vascular patterns provide therapeutic targets in aggressive neuroblastic tumors.

Authors:  Irene Tadeo; Gloria Bueno; Ana P Berbegall; M Milagro Fernández-Carrobles; Victoria Castel; Marcial García-Rojo; Samuel Navarro; Rosa Noguera
Journal:  Oncotarget       Date:  2016-04-12

6.  Pancreatic stellate cells regulate blood vessel density in the stroma of pancreatic ductal adenocarcinoma.

Authors:  Francesco Di Maggio; Prabhu Arumugam; Francesca R Delvecchio; Silvia Batista; Tanguy Lechertier; Kairbaan Hodivala-Dilke; Hemant M Kocher
Journal:  Pancreatology       Date:  2016-06-01       Impact factor: 3.996

7.  Network Meta-Analysis of Efficacy and Safety of Chemotherapy and Target Therapy in the First-Line Setting of Advanced Pancreatic Cancer.

Authors:  Kun-I Lin; Jia-Lian Yang; Yu-Chao Lin; Che-Yi Chou; Jin-Hua Chen; Chin-Chuan Hung
Journal:  Cancers (Basel)       Date:  2019-11-07       Impact factor: 6.639

8.  Quantitative parameters of intravoxel incoherent motion diffusion weighted imaging (IVIM-DWI): potential application in predicting pathological grades of pancreatic ductal adenocarcinoma.

Authors:  Wanling Ma; Guangwen Zhang; Jing Ren; Qi Pan; Didi Wen; Jinman Zhong; Zhuoli Zhang; Yi Huan
Journal:  Quant Imaging Med Surg       Date:  2018-04

9.  Lymph microvascularization as a prognostic indicator in neuroblastoma.

Authors:  Irene Tadeo; Esther Gamero-Sandemetrio; Ana P Berbegall; Marta Gironella; Félix Ritort; Adela Cañete; Gloria Bueno; Samuel Navarro; Rosa Noguera
Journal:  Oncotarget       Date:  2018-05-25

10.  SonoVue® vs. Sonazoid™ vs. Optison™: Which Bubble Is Best for Low-Intensity Sonoporation of Pancreatic Ductal Adenocarcinoma?

Authors:  Spiros Kotopoulis; Mihaela Popa; Mireia Mayoral Safont; Elisa Murvold; Ragnhild Haugse; Anika Langer; Georg Dimcevski; Christina Lam; Tormod Bjånes; Odd Helge Gilja; Emmet Mc Cormack
Journal:  Pharmaceutics       Date:  2022-01-01       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.